Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
eFFECTOR Therapeutics (EFTR)
NASDAQ:EFTR
eFFECTOR Therapeutics (EFTR) Stock Price & Analysis
78 Followers
EFTR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.36 - $5.97
Previous Close$0.51
Volume210.60K
Average Volume (3M)299.51K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)3.6
Beta-0.09
Next EarningsMar 15, 2023
EPS Estimate-$0.24
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$4.33
EPS (TTM)0.14
Shares Outstanding41,893,140
R-Squared0.00220
Standard Deviation0.21
10 Day Avg. Volume660,896
30 Day Avg. Volume299,514
Price to Book (P/B)1.64
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside750.85% Upside
Rating ConsensusStrong Buy
Alpha-0.12
Number of Analyst Covering4
eFFECTOR Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EFTR FAQ
What was eFFECTOR Therapeutics’s price range in the past 12 months?
eFFECTOR Therapeutics lowest stock price was $0.36 and its highest was $5.97 in the past 12 months.
What is eFFECTOR Therapeutics’s market cap?
Currently, no data Available
When is eFFECTOR Therapeutics’s upcoming earnings report date?
eFFECTOR Therapeutics’s upcoming earnings report date is Mar 15, 2023 which is in 45 days.
How were eFFECTOR Therapeutics’s earnings last quarter?
eFFECTOR Therapeutics released its earnings results on Nov 07, 2022. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.214 by -$0.016.
Is eFFECTOR Therapeutics overvalued?
According to Wall Street analysts eFFECTOR Therapeutics’s price is currently Undervalued.
Does eFFECTOR Therapeutics pay dividends?
eFFECTOR Therapeutics does not currently pay dividends.
What is eFFECTOR Therapeutics’s EPS estimate?
eFFECTOR Therapeutics’s EPS estimate is -$0.24.
How many shares outstanding does eFFECTOR Therapeutics have?
eFFECTOR Therapeutics has 41,348,310 shares outstanding.
What happened to eFFECTOR Therapeutics’s price movement after its last earnings report?
eFFECTOR Therapeutics reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.214. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of eFFECTOR Therapeutics?
Among the largest hedge funds holding eFFECTOR Therapeutics’s share is Blackstone Inc.. It holds eFFECTOR Therapeutics’s shares valued at 749K.
---
eFFECTOR Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.33
$4.33
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.67%
12-Months-Change
Fundamentals
Return on Equity
290.11%
Trailing 12-Months
Asset Growth
-38.85%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
eFFECTOR Therapeutics
Locust Walk Acquisition Corp is a blank check company.
---
Minerva Neurosciences
―
Blue Water Vaccines, Inc.
―
Aridis Pharmaceuticals
―
Metacrine
―
Catalyst Biosciences
―
---